Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: Half the price · white product still. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The headline is two short sentences, each making one claim, which makes it easy to read in a feed: a quality claim followed by a price claim. The white background and black type give it a clinical, trustworthy feel compared with Ro's colorful variants, and the hand holding the pen (with the same yellow nails seen in other Ro pen ads) keeps the product human. The comparison basis for half the price sits directly under the headline.
Both claims are comparisons, and the ad doesn't show either reference point in a way a newcomer would understand: most effective compared with what, and half of which price? The footnote explains the price, but the effectiveness claim has no visible basis in the frame. If you make one like this, keep the two-sentence headline but add a short line that names the comparison for the first claim too, so neither one asks the viewer to take it on faith.
Two short sentences deliver a quality claim and a price claim in one read.
It gives the price claim its basis right under the headline.
The held product feels real, and the sticker marks it as a launch.
Half the price, framed against the manufacturer list price of the Zepbound autoinjector pen when paying cash.
The ad sends people to Ro's quiz entry, where they can choose GLP-1 shot as their first answer, which suits someone who clicked on this pen ad. By the persona's ladder, the quiz is a stronger landing than a product page. But neither claim from the headline appears on the page; the only cost message is a general line about lowest prices in the top bar. Repeating Half the price beside the shot option would carry the main promise forward.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.